// App-Quantinova.ai

981 : Do Acetylcholinesterase Inhibitors (AChEI) delay institutionalisation in Parkinson’s and Lewy Body Disease?

Researchers

Presenter

  • L. Brown

Principal Investigators

  • B. Mohamed

  • E. Thomas

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Lewy body dementia

  • Parkinson's disease

Biomarkers

  • Acetylcholinesterase

Drug/Treatment

  • Rivastigmine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved